![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Basf Se Ludwigshafen De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Macrogols, Type 3350, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2011-028 - Rev 01
This Chemical Type CEP, issued on March 17, 2020, remains in force until January 24, 2024, ensuring its reliability within the pharmaceutical industry.
Substance Number 1444 associated with this CEP further emphasizes